| Not Yet Recruiting | Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe. Immunization, Influenza (Healthy Volunteers) | — | 2026-10-01 |
| Not Yet Recruiting | Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe Influenza Immunization, Healthy Volunteers | — | 2026-10-01 |
| Not Yet Recruiting | A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Cr Colitis Ulcerative, Crohn's Disease | Phase 2 | 2026-05-12 |
| Not Yet Recruiting | A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japan Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2026-05-08 |
| Not Yet Recruiting | A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versu Chronic Graft Versus Host Disease | Phase 4 | 2026-04-15 |
| Not Yet Recruiting | Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica Polymyalgia Rheumatica | Phase 4 | 2026-04-15 |
| Not Yet Recruiting | Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Parti Respiratory Syncytial Virus (RSV), Influenza A(H5N1) | Phase 1 | 2026-04-13 |
| Recruiting | Long-Term Outcomes of Teplizumab in Routine Clinical Care Type 1 Diabetes | — | 2026-03-19 |
| Recruiting | A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chr Chronic Spontaneous Urticaria | — | 2026-03-18 |
| Recruiting | Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs ( Type 1 Diabetes | — | 2026-03-16 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Tra Kidney Transplant Rejection | Phase 2 / Phase 3 | 2026-03-13 |
| Enrolling By Invitation | An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants Wi Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2026-03-12 |
| Recruiting | The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopi Atopic Dermatitis | — | 2026-02-24 |
| Recruiting | Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcome Chronic Obstructive Pulmonary Disease COPD | — | 2026-01-28 |
| Recruiting | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Sev Crohn's Disease | Phase 3 | 2026-01-22 |
| Recruiting | Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Pneumococcal Immunization, Healthy Volunteers | Phase 3 | 2026-01-20 |
| Recruiting | Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle C Sickle Cell Disease | Phase 3 | 2026-01-20 |
| Recruiting | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Sev Ulcerative Colitis | Phase 3 | 2026-01-16 |
| Recruiting | Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adul Multiple Sclerosis | Phase 3 | 2026-01-14 |
| Recruiting | A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidrad Hidradenitis Suppurativa | Phase 2 | 2025-12-29 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Th Hemophilia | Phase 3 | 2025-12-18 |
| Recruiting | Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) Type 1 Diabetes | N/A | 2025-12-17 |
| Recruiting | A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Cardiac Repolarization, Healthy Volunteers | Phase 1 | 2025-12-04 |
| Recruiting | A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) Chronic Graft Versus Host Disease | Phase 2 | 2025-12-02 |
| Recruiting | This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Wh Atopic Dermatitis | — | 2025-11-17 |
| Recruiting | Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2025-11-06 |
| Recruiting | A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Parti Type 1 Diabetes | — | 2025-10-31 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) W Immune Thrombocytopenia | Phase 3 | 2025-10-24 |
| Active Not Recruiting | Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan Immune Thrombocytopenia | Phase 3 | 2025-10-15 |
| Recruiting | A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Rem Microscopic Colitis | Phase 2 | 2025-10-14 |
| Active Not Recruiting | Safety and Immunogenicity of NVX-CoV2705 COVID-19, SARS-CoV-2 Infection | Phase 3 | 2025-10-09 |
| Recruiting | A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Geographic Atrophy | Phase 1 / Phase 2 | 2025-10-09 |
| Recruiting | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Seve Ulcerative Colitis | Phase 3 | 2025-10-08 |
| Recruiting | A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea Respiratory Syncytial Virus | — | 2025-10-02 |
| Recruiting | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Seve Crohn's Disease | Phase 3 | 2025-10-01 |
| Active Not Recruiting | Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administere Meningococcal Infection, Healthy Volunteers | Phase 3 | 2025-09-26 |
| Recruiting | A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Immunoglobulin G4 Related Disease | Phase 3 | 2025-09-26 |
| Recruiting | Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy Factor VIII Deficiency | Phase 4 | 2025-09-23 |
| Recruiting | A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years Chronic Obstructive Pulmonary Disease | Phase 4 | 2025-09-22 |
| Recruiting | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadeq Chronic Obstructive Pulmonary Disease | Phase 3 | 2025-09-17 |
| Recruiting | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadeq Chronic Obstructive Pulmonary Disease | Phase 3 | 2025-09-16 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease Graves' Disease | Phase 2 | 2025-09-02 |
| Active Not Recruiting | A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants Healthy Volunteers | Phase 1 | 2025-08-25 |
| Recruiting | A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo Autoimmune Haemolytic Anaemia | Phase 3 | 2025-08-18 |
| Recruiting | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease Sickle Cell Disease | Phase 3 | 2025-08-12 |
| Recruiting | A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years o Type 1 Diabetes Mellitus | Phase 3 | 2025-08-06 |
| Active Not Recruiting | Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Mon RSV Immunization | Phase 4 | 2025-07-31 |
| Recruiting | Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes Type 1 Diabetes Mellitus | Phase 2 | 2025-07-25 |
| Recruiting | A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-m Myotonic Dystrophy | Phase 1 / Phase 2 | 2025-07-23 |
| Active Not Recruiting | Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncyti Respiratory Syncytial Virus Immunization | Phase 1 | 2025-07-14 |
| Recruiting | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population Yellow Fever Immunization | Phase 3 | 2025-07-11 |
| Recruiting | A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2025-07-07 |
| Recruiting | Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Chronic Obstructive Pulmonary Disease (COPD) | — | 2025-07-01 |
| Completed | Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combi Rhinitis Allergic | Phase 4 | 2025-06-15 |
| Recruiting | A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease Crohn's Disease | Phase 2 | 2025-06-03 |
| Active Not Recruiting | Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age Pneumococcal Immunization, Healthy Volunteers | Phase 3 | 2025-05-22 |
| Completed | Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults Yellow Fever Immunization | Phase 3 | 2025-05-22 |
| Recruiting | Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2025-05-12 |
| Active Not Recruiting | A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Rheumatoid Arthritis, Psoriatic Arthritis | — | 2025-05-05 |
| Active Not Recruiting | A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Ar Epilepsy, Seizures | — | 2025-04-29 |
| Active Not Recruiting | Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Pandemic Influenza Immunization, Healthy Volunteers | Phase 1 / Phase 2 | 2025-04-17 |
| Recruiting | Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneurop Polyneuropathy, Inflammatory Demyelinating, Chronic | — | 2025-04-11 |
| Enrolling By Invitation | Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP Polyneuropathy, Inflammatory Demyelinating, Chronic | Phase 3 | 2025-04-01 |
| Recruiting | A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis Colitis Ulcerative | Phase 2 | 2025-03-28 |
| Recruiting | A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Disease Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) | Phase 1 | 2025-03-27 |
| Recruiting | Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years Chlamydia Trachomatis Immunization | Phase 1 / Phase 2 | 2025-03-27 |
| Completed | A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Healthy Volunteers, Influenza Vaccination, Respiratory Syncytial Virus Vaccination | Phase 1 | 2025-03-19 |
| Recruiting | A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adu Plasma Cell Myeloma Refractory | Phase 2 | 2025-03-17 |
| Active Not Recruiting | Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany Chlamydia Trachomatis | — | 2025-03-13 |
| Active Not Recruiting | Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule Type 1 Diabetes Mellitus | Phase 2 | 2025-02-28 |
| Active Not Recruiting | Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococ Pneumococcal Immunization | Phase 3 | 2025-02-27 |
| Active Not Recruiting | Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Mont Pneumococcal Immunization | Phase 3 | 2025-02-18 |
| Recruiting | A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participant Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2025-02-12 |
| Completed | Description of Patients With Type 1 Diabetes Treated With Teplizumab Type 1 Diabetes | — | 2025-02-11 |
| Recruiting | A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participant Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2025-02-06 |
| Recruiting | French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD) Atopic Dermatitis | — | 2025-02-04 |
| Recruiting | Actual Use Trial of Tadalafil 5 mg Erectile Dysfunction | Phase 3 | 2025-01-30 |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Dermatitis Atopic | Phase 2 | 2025-01-30 |
| Completed | Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP) Chronic Immune Thrombocytopenia, Primary Immune Thrombocytopenia, Adult Immune Thrombocytopenia | — | 2025-01-13 |
| Active Not Recruiting | A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 4 | 2025-01-06 |
| Recruiting | Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data Chlamydial Infections | — | 2025-01-01 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 1 Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion | Phase 2 | 2024-12-19 |
| Active Not Recruiting | A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Pa Chronic Rhinosinusitis Without Nasal Polyps | Phase 2 | 2024-12-16 |
| Recruiting | A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. Crohn's Disease | Phase 2 | 2024-12-10 |
| Recruiting | iGlarLixi CGM Study in Chinese T2D Individuals After OADs Type 2 Diabetes (T2D) | Phase 4 | 2024-12-10 |
| Active Not Recruiting | A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents Chronic Graft Versus Host Disease | Phase 4 | 2024-12-04 |
| Recruiting | A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatmen Eosinophilic Esophagitis | — | 2024-12-02 |
| Active Not Recruiting | A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared Lichen Simplex Chronicus | Phase 3 | 2024-11-28 |
| Terminated | Goal Attainment and Physical Activity in People With Hemophilia A Hemophilia A | — | 2024-11-26 |
| Active Not Recruiting | A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared Lichen Simplex Chronicus | Phase 3 | 2024-11-25 |
| Recruiting | A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration Neovascular Age-related Macular Degeneration | Phase 1 / Phase 2 | 2024-11-21 |
| Active Not Recruiting | An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Subst Dermatitis Atopic | Phase 1 | 2024-11-20 |
| Completed | A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis Osteoarthritis | Phase 1 | 2024-11-20 |
| Active Not Recruiting | Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvante COVID-19 Immunization, Influenza Immunization | Phase 1 / Phase 2 | 2024-11-19 |
| Active Not Recruiting | Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvante COVID-19 Immunization, Influenza Immunization | Phase 1 / Phase 2 | 2024-11-18 |
| Completed | A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Influenza Immunization, Health Volunteers | — | 2024-11-18 |
| Active Not Recruiting | Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain Atopic Dermatitis | — | 2024-11-14 |
| Recruiting | A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A i Hemophilia A | — | 2024-11-11 |
| Recruiting | Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Asthma | Phase 2 | 2024-11-07 |
| Recruiting | A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Plasma Cell Myeloma Refractory | Phase 1 | 2024-10-30 |
| Withdrawn | A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Allogenic Stem Cell Transplantation | Phase 2 | 2024-10-08 |
| Recruiting | Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma. Asthma | Phase 2 | 2024-09-30 |
| Recruiting | Registry for Stage 2 Type 1 Diabetes Type 1 Diabetes | — | 2024-09-27 |
| Active Not Recruiting | A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Coeliac Disease, Celiac Disease | Phase 2 | 2024-08-29 |
| Recruiting | A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobul Chronic Inflammatory Demyelinating Polyneuropathy | Phase 3 | 2024-08-21 |
| Terminated | A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hema Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2024-08-13 |
| Active Not Recruiting | A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2024-07-17 |
| Recruiting | A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyne Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic | Phase 3 | 2024-07-12 |
| Recruiting | A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell B-cell Non Hodgkin Lymphoma | Phase 1 | 2024-07-08 |
| Active Not Recruiting | Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema Alpha 1-Antitrypsin Deficiency, Emphysema | Phase 2 | 2024-06-20 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in A Alopecia Areata | Phase 2 | 2024-06-06 |
| Recruiting | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Prurigo Nodularis | Phase 3 | 2024-05-15 |
| Active Not Recruiting | A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compare Dermatitis Atopic | Phase 3 | 2024-05-08 |
| Active Not Recruiting | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Scleros Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis | Phase 3 | 2024-04-16 |
| Recruiting | A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Th Niemann-Pick Diseases, Acid Sphingomyelinase Deficiency | — | 2024-04-16 |
| Completed | Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Gaucher Disease | N/A | 2024-04-02 |
| Completed | A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants Autoimmune Disorder, Healthy Volunteers | Phase 1 | 2024-03-25 |
| Recruiting | A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously R Hemophilia A | Phase 4 | 2024-03-01 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Dermatitis Atopic | Phase 3 | 2024-02-29 |
| Active Not Recruiting | A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermat Dermatitis Atopic | Phase 4 | 2024-02-22 |
| Completed | A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Par Bronchiectasis | Phase 2 | 2024-02-20 |
| Active Not Recruiting | A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Chronic Graft Versus Host Disease | Phase 3 | 2024-01-23 |
| Completed | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Olde Dermatitis Atopic | Phase 3 | 2024-01-18 |
| Active Not Recruiting | A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD Chronic Obstructive Pulmonary Disease | Phase 3 | 2024-01-11 |
| Recruiting | Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years Wheezing, Asthma | Phase 3 | 2024-01-03 |
| Active Not Recruiting | Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination D Pertussis (Whooping Cough) | — | 2024-01-02 |
| Recruiting | Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Multiple Sclerosis | Phase 3 | 2023-12-27 |
| Recruiting | A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes Prurigo Nodularis | — | 2023-12-27 |
| Completed | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in P Dermatitis Atopic | Phase 3 | 2023-12-21 |
| Recruiting | Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis Multiple Sclerosis | Phase 3 | 2023-12-13 |
| Active Not Recruiting | Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study Prurigo Nodularis | — | 2023-12-12 |
| Recruiting | FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on To Type 1 Diabetes Mellitus | Phase 2 | 2023-12-11 |
| Recruiting | A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions ( Dermatitis Atopic | — | 2023-11-30 |
| Active Not Recruiting | A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followe Eosinophilic Oesophagitis | Phase 4 | 2023-11-29 |
| Active Not Recruiting | A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Re Atopic Dermatitis | — | 2023-11-28 |
| Completed | A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme Fabry's Disease | Phase 4 | 2023-11-10 |
| Terminated | Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2023-11-09 |
| Completed | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in P Dermatitis Atopic | Phase 3 | 2023-11-08 |
| Completed | A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2023-11-07 |
| Terminated | Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidra Hidradenitis | Phase 2 | 2023-11-01 |
| Completed | A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis Psoriasis | Phase 2 | 2023-10-26 |
| Active Not Recruiting | Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France Chronic Rhinosinusitis With Nasal Polyposis | — | 2023-10-20 |
| Completed | Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe A Asthma | Phase 2 | 2023-10-16 |
| Completed | Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema Alpha 1-Antitrypsin Deficiency, Emphysema | Phase 2 | 2023-10-12 |
| Active Not Recruiting | Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Moderate to Severe Atopic Dermatitis | — | 2023-10-10 |
| Recruiting | A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allogr Lung Transplant Rejection | Phase 3 | 2023-10-10 |
| Terminated | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants Osteochondrodysplasia | Phase 2 | 2023-10-10 |
| Completed | A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Ag Dermatitis Atopic | Phase 2 | 2023-10-06 |
| Completed | A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Asthma | — | 2023-10-03 |
| Completed | Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2 Influenza Immunization (Healthy Volunteers) | — | 2023-10-02 |
| Terminated | A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants W Hidradenitis Suppurativa | Phase 2 | 2023-09-29 |
| Active Not Recruiting | Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan Fabry Disease | — | 2023-09-13 |
| Active Not Recruiting | Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-se Asthma | Phase 2 | 2023-09-05 |
| Active Not Recruiting | A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Phenylketonuria | Phase 1 / Phase 2 | 2023-08-07 |
| Completed | Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry) Fabry Disease | — | 2023-07-28 |
| Active Not Recruiting | Teplizumab in Pediatric Stage 2 Type 1 Diabetes Diabetes Mellitus, Type 1 | Phase 4 | 2023-07-25 |
| Active Not Recruiting | A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A Hemophilia A | — | 2023-06-30 |
| Terminated | A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Acute Myeloid Leukaemia | Phase 1 | 2023-06-16 |
| Completed | A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2023-06-06 |
| Completed | A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 Rheumatoid Arthritis | Phase 1 | 2023-05-22 |
| Completed | Dupilumab in Chinese Adult Participants With CRSwNP Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2023-05-16 |
| Completed | A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in H Rheumatoid Arthritis | Phase 1 | 2023-05-15 |
| Terminated | A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple My Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis | Phase 1 / Phase 2 | 2023-05-15 |
| Terminated | Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Pop Venous Thromboembolism | — | 2023-04-25 |
| Terminated | A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) f Venous Thromboembolism | — | 2023-04-25 |
| Completed | An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Cli Asthma | — | 2023-04-19 |
| Active Not Recruiting | A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Part Relapsed/Refractory Multiple Myeloma | Phase 2 | 2023-04-05 |
| Active Not Recruiting | International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clini Plasma Cell Myeloma | Phase 2 | 2023-04-05 |
| Recruiting | Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Dermatitis Atopic | Phase 2 | 2023-04-03 |
| Recruiting | Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Derm Atopic Dermatitis | — | 2023-03-07 |
| Completed | Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China Atopic Dermatitis | Phase 4 | 2023-02-22 |
| Completed | A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adul Type 2 Diabetes Mellitus | N/A | 2023-02-17 |
| Active Not Recruiting | A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adoles Hemophilia | Phase 3 | 2023-02-01 |
| Completed | A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild Hepatic Function Abnormal | Phase 1 | 2023-01-18 |
| Completed | A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokineti Hepatic Function Abnormal | Phase 1 | 2023-01-18 |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged Colitis Ulcerative | Phase 2 | 2023-01-12 |
| Completed | A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermat Atopic Dermatitis | — | 2022-12-30 |
| Terminated | A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participant Multiple Sclerosis | Phase 2 | 2022-12-19 |
| Terminated | Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment Type 2 Diabetes Mellitus, Renal Impairment | Phase 4 | 2022-12-05 |
| Completed | A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellit Type 2 Diabetes Mellitus (T2DM) | — | 2022-11-30 |
| Recruiting | A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced So Solid Tumor | Phase 1 / Phase 2 | 2022-11-29 |
| Completed | Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China Atopic Dermatitis, Dermatitis Atopic | Phase 4 | 2022-11-25 |
| Active Not Recruiting | Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis Colitis Ulcerative | Phase 2 | 2022-11-25 |
| Completed | Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune Thrombotic Thrombocytopenic Purpura | Phase 3 | 2022-11-21 |
| Completed | A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gul Chronic Rhinosinusitis With Nasal Polyps | — | 2022-11-20 |
| Recruiting | Avalglucosidase Alfa Pregnancy Study Pompe Disease, Pregnancy | — | 2022-10-26 |
| Completed | A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Type 2 Diabetes Mellitus (T2DM) | — | 2022-10-05 |
| Terminated | Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors Neoplasm | Phase 1 | 2022-10-03 |
| Terminated | Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumor Neoplasm | Phase 1 / Phase 2 | 2022-09-20 |
| Terminated | Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI) Osteogenesis Imperfecta | Phase 1 | 2022-08-25 |
| Completed | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of A Chronic Spontaneous Urticaria | Phase 3 | 2022-08-25 |
| Enrolling By Invitation | Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Se Dermatitis Atopic | Phase 2 / Phase 3 | 2022-08-22 |
| Completed | A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan Atopic Dermatitis | — | 2022-07-20 |
| Completed | Real World Study on the Use of Cemiplimab in Adult Patients in UK Cutaneous Squamous Cell Carcinoma | — | 2022-07-18 |
| Completed | A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Part Psoriasis | Phase 1 | 2022-07-12 |
| Completed | iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) Type 2 Diabetes Mellitus | Phase 3 | 2022-07-07 |
| Completed | Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma Asthma | Phase 2 | 2022-06-30 |
| Active Not Recruiting | SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM Plasma Cell Myeloma Recurrent | Phase 3 | 2022-06-23 |
| Completed | Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access Acid Sphingomyelinase Deficiency (ASMD) | — | 2022-06-10 |
| Active Not Recruiting | BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) Transplant Rejection | Phase 2 | 2022-06-09 |
| Completed | First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants Asthma | Phase 1 | 2022-06-08 |
| Completed | Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura ( Immune-mediated Thrombocytopenic Purpura | — | 2022-06-08 |
| Terminated | Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Non-squamous Non-small Cell Lung Cancer | Phase 2 | 2022-06-01 |
| Completed | Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD Chronic Obstructive Pulmonary Disease | Phase 2 | 2022-05-19 |
| Active Not Recruiting | A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult P Fabry Disease | Phase 3 | 2022-05-03 |
| Completed | A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants Healthy Volunteers | Phase 1 | 2022-04-28 |
| Active Not Recruiting | Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease T Gaucher's Disease Type III | Phase 3 | 2022-04-18 |
| Terminated | Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis | Phase 2 | 2022-04-13 |
| Completed | Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hep Hepatic Function Abnormal | Phase 1 | 2022-03-18 |
| Active Not Recruiting | A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Part Fabry Disease | Phase 3 | 2022-03-11 |
| Completed | Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Im Renal Impairment | Phase 1 | 2022-03-10 |
| Completed | A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Amyotrophic Lateral Sclerosis, Healthy Volunteer | Phase 1 | 2022-02-18 |
| Terminated | Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Bre Breast Cancer | Phase 3 | 2022-02-17 |
| Completed | A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quant Dermatitis Atopic | — | 2022-02-17 |
| Recruiting | Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Pruritus | Phase 3 | 2022-02-15 |
| Completed | Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Ve Type 2 Diabetes Mellitus | Phase 4 | 2022-01-27 |
| Completed | A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants Dermatitis Atopic | — | 2022-01-18 |
| Completed | Comparative Efficacy of Cemiplimab to Historical Standard of Care in France Cancer/Squamous Cell Carcinoma of Skin | — | 2022-01-17 |
| Active Not Recruiting | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients Wit Asthma | Phase 4 | 2021-12-16 |
| Completed | Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma Asthma | Phase 2 | 2021-12-12 |
| Completed | A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastroint Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma | Phase 2 | 2021-12-09 |
| Terminated | First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia Refractory, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2021-12-08 |
| Active Not Recruiting | Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIH Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase 2 | 2021-12-07 |
| Terminated | A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents Wi Classic Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | 2021-12-07 |
| Terminated | Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Grav Myasthenia Gravis | Phase 3 | 2021-12-03 |
| Completed | Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite th Chronic Spontaneous Urticaria | Phase 2 | 2021-11-24 |
| Completed | A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sp Acid Sphingomyelinase Deficiency | Phase 2 | 2021-11-18 |
| Completed | Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY A Primary Hypercholesterolaemia and Mixed Dyslipidaemia, Atherosclerotic Cardiovascular Disease | — | 2021-11-18 |
| Terminated | Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Can Adenocarcinoma Gastric, Gastrooesophageal Cancer | Phase 2 | 2021-11-16 |
| Terminated | Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Norm Hepatic Function Abnormal | Phase 1 | 2021-11-15 |
| Completed | Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Cold Agglutinin Disease | Phase 3 | 2021-11-11 |
| Active Not Recruiting | Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2021-11-10 |
| Completed | A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dup Asthma | — | 2021-11-04 |
| Completed | Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain Low Back Pain | Phase 3 | 2021-11-04 |
| Completed | Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients Autologous Haematopoietic Stem Cell Transplant | Phase 4 | 2021-10-22 |
| Completed | Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52) Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | 2021-10-22 |
| Completed | Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Hea Healthy Volunteer | Phase 1 | 2021-10-15 |
| Completed | A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group W Pompe Disease, Mucopolysaccharidosis Type I (MPS I) | — | 2021-10-14 |
| Completed | A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | 2021-10-11 |
| Terminated | A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Ma Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2021-10-08 |
| Completed | EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | 2021-09-27 |
| Completed | Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation Atrial Fibrillation | — | 2021-09-24 |
| Terminated | A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Canc Pleural Mesothelioma, Non-small Cell Lung Cancer | Phase 2 | 2021-09-23 |
| Completed | Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled S Chronic Obstructive Pulmonary Disease | Phase 1 | 2021-09-16 |
| Terminated | Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Ane Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase 2 | 2021-09-09 |
| Completed | Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2021-09-09 |
| Active Not Recruiting | Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alf Glycogen Storage Disease Type II | Phase 3 | 2021-09-01 |
| Terminated | Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Soli Neoplasm Malignant, Breast Cancer, Lung Neoplasm Malignant | Phase 1 | 2021-08-16 |
| Completed | Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctoco Hemophilia A | Phase 1 | 2021-08-11 |
| Completed | Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants Multiple Sclerosis Healthy Subjects | Phase 1 | 2021-08-05 |
| Completed | A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Abs Amyotrophic Lateral Sclerosis (Healthy Volunteers) | Phase 1 | 2021-07-28 |
| Terminated | A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Can Malignant Melanoma, Squamous Cell Carcinoma of Skin | Phase 1 / Phase 2 | 2021-07-15 |
| Completed | A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen Gaucher Disease, Splenomegaly, Acid SphingoMyelinase Deficiency | — | 2021-06-30 |
| Completed | Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioav Breast Cancer, Healthy Volunteers | Phase 1 | 2021-06-15 |
| Active Not Recruiting | A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Mon Glycogen Storage Disease Type II | — | 2021-06-10 |
| Completed | Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Heal Healthy Volunteers | Phase 1 | 2021-06-08 |
| Active Not Recruiting | Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis Multiple Sclerosis | Phase 2 | 2021-06-07 |
| Completed | Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Ty Type 2 Diabetes Mellitus | Phase 4 | 2021-06-07 |
| Completed | A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type Type 2 Diabetes Mellitus | Phase 4 | 2021-05-20 |
| Completed | Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis Dermatitis Atopic | Phase 4 | 2021-04-22 |
| Terminated | Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Cancer, Neoplasm | Phase 1 / Phase 2 | 2021-04-11 |
| Completed | Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus Cutaneous Lupus Erythematosus | Phase 2 | 2021-04-01 |
| Terminated | Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors Breast Cancer Metastatic, Pancreatic Carcinoma Metastatic | Phase 2 | 2021-03-29 |
| Completed | Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Gaucher's Disease | Phase 4 | 2021-03-02 |
| Completed | Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis Dermatitis Atopic | Phase 4 | 2021-02-19 |
| Completed | Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Chronic Obstructive Pulmonary Disease | Phase 3 | 2021-02-12 |
| Terminated | Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat Congenital Cystic Kidney Disease | Phase 3 | 2021-02-09 |
| Recruiting | Isatuximab in Combination With Novel Agents in RRMM - Master Protocol Plasma Cell Myeloma Refractory | Phase 1 / Phase 2 | 2021-01-25 |
| Completed | Dupilumab in Japanese Patients With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2021-01-15 |
| Completed | Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Chronic Obstructive Pulmonary Disease | Phase 3 | 2020-12-16 |
| Completed | Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Cold Urticaria | Phase 3 | 2020-12-10 |
| Completed | A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chi Hypercholesterolemia | Phase 3 | 2020-12-08 |
| Completed | Dupilumab in CRSsNP Chronic Rhinosinusitis Without Nasal Polyps, Sinusitis, Chronic Sinusitis | Phase 3 | 2020-12-02 |
| Completed | Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) Allergic Fungal Rhinosinusitis | Phase 3 | 2020-12-01 |
| Completed | Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants Amyotrophic Lateral Sclerosis (Healthy Volunteers) | Phase 1 | 2020-11-30 |
| Completed | A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects Osteochondrodysplasia | Phase 1 | 2020-11-18 |
| Completed | Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (p Sjögren's Syndrome, Sjogren's Syndrome | Phase 2 | 2020-11-12 |
| Active Not Recruiting | Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patie Asthma | — | 2020-11-02 |
| Terminated | Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) | Phase 2 | 2020-10-26 |
| Terminated | Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Brea Breast Cancer | Phase 3 | 2020-10-14 |
| Completed | Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years. Pneumococcal Immunization | Phase 2 | 2020-10-08 |
| Completed | Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibit Non-relapsing Secondary Progressive Multiple Sclerosis | Phase 3 | 2020-09-24 |
| Withdrawn | To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Ver Fabry Disease | Phase 4 | 2020-09-01 |
| Terminated | Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretrea Non-small Cell Lung Cancer Metastatic | Phase 2 | 2020-08-31 |
| Completed | Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib ( Primary Progressive Multiple Sclerosis | Phase 3 | 2020-08-13 |
| Active Not Recruiting | A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapse Plasma Cell Myeloma | — | 2020-08-13 |
| Completed | A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Du Asthma | Phase 4 | 2020-08-10 |
| Completed | Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Multiple Sclerosis | Phase 1 | 2020-08-10 |
| Active Not Recruiting | First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL Neoplasm Malignant | Phase 1 | 2020-07-24 |
| Completed | A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 Corona Virus Infection | Phase 1 | 2020-07-17 |
| Completed | Dupilumab Skin Barrier Function Study in Atopic Dermatitis Atopic Dermatitis | Phase 4 | 2020-07-16 |
| Completed | Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | Phase 3 | 2020-07-06 |
| Completed | Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SA Relapsing Multiple Sclerosis | Phase 3 | 2020-06-30 |
| Completed | A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Par Healthy Volunteers | Phase 1 | 2020-06-23 |
| Completed | The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Re Asthma | Phase 4 | 2020-06-20 |
| Completed | A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Pa Healthy Volunteers | Phase 1 | 2020-06-18 |
| Terminated | Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation Immune System Disorder | Phase 1 / Phase 2 | 2020-06-18 |
| Active Not Recruiting | Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma Plasma Cell Myeloma | Phase 3 | 2020-06-16 |
| Completed | Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SA Relapsing Multiple Sclerosis | Phase 3 | 2020-06-11 |
| Terminated | Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancie Metastatic Neoplasm | Phase 1 / Phase 2 | 2020-06-09 |
| Completed | Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meni Meningococcal Immunisation (Healthy Volunteers) | Phase 3 | 2020-05-22 |
| Completed | Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Pat Multiple Sclerosis | Phase 4 | 2020-05-20 |
| Completed | Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subj Multiple Sclerosis | Phase 1 | 2020-05-18 |
| Terminated | Efficacy and Safety of Teicoplanin in CDAD Clostridium Difficile Infection-associated Diarrhea and Colitis | Phase 4 | 2020-05-15 |
| Completed | Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia Lymphoma | Phase 4 | 2020-05-14 |
| Terminated | Hydroxychloroquine in Outpatient Adults With COVID-19 Coronavirus Infection | Phase 1 | 2020-04-12 |
| Completed | Sarilumab COVID-19 Corona Virus Infection | Phase 3 | 2020-03-28 |
| Active Not Recruiting | SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (C Non-small Cell Lung Cancer Metastatic | Phase 3 | 2020-02-06 |
| Terminated | Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Breast Cancer | Phase 2 | 2020-02-04 |
| Completed | Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Pr Neurodermatitis | Phase 3 | 2020-01-16 |
| Completed | Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Pr Neurodermatitis | Phase 3 | 2019-12-12 |
| Completed | Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Us Chronic Spontaneous Urticaria | Phase 3 | 2019-12-11 |
| Completed | Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects Multiple Sclerosis | Phase 1 | 2019-11-13 |
| Terminated | Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-posit Breast Cancer Metastatic | Phase 2 | 2019-10-22 |
| Completed | A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Thrombotic Thrombocytopenic Purpura | Phase 2 / Phase 3 | 2019-10-21 |
| Completed | Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring i Type 1 Diabetes Mellitus | Phase 4 | 2019-10-09 |
| Completed | Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Influenza | — | 2019-10-05 |
| Completed | A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficienc Sphingomyelin Lipidosis | N/A | 2019-09-27 |
| Completed | Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclero Relapsing Multiple Sclerosis | Phase 2 | 2019-09-23 |
| Completed | SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" Atopic Dermatitis | Phase 4 | 2019-08-22 |
| Completed | First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma Plasma Cell Myeloma | Phase 1 | 2019-08-19 |
| Active Not Recruiting | Observational Evaluation of Atopic Dermatitis in Pediatric Patients Dermatitis Atopic | — | 2019-08-15 |
| Completed | Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Multiple Myeloma | Phase 1 | 2019-08-06 |
| Terminated | Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2019-08-06 |
| Terminated | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Con Type 2 Diabetes Mellitus | Phase 3 | 2019-08-01 |
| Completed | Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High C Type 2 Diabetes Mellitus | Phase 4 | 2019-06-29 |
| Active Not Recruiting | Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) Dermatitis Atopic | — | 2019-06-11 |
| Withdrawn | Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Non-alcoholic Steatohepatitis, Type 2 Diabetes Mellitus | Phase 2 | 2019-05-23 |
| Completed | Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects Diabetes Mellitus | Phase 1 | 2019-04-28 |
| Completed | First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to O Overweight, Healthy Subjects | Phase 1 | 2019-04-25 |
| Completed | Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease | Phase 3 | 2019-04-15 |
| Active Not Recruiting | Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY) Dermatitis Atopic | — | 2019-04-05 |
| Completed | Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis Relapsing Multiple Sclerosis | Phase 2 | 2019-03-29 |
| Completed | To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis Relapsing Multiple Sclerosis | Phase 4 | 2019-03-27 |
| Completed | A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type Type 1 Diabetes | Phase 1 | 2019-03-26 |
| Terminated | Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced B Breast Cancer | Phase 1 | 2019-03-25 |
| Completed | Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agoni Type 2 Diabetes Mellitus | Phase 3 | 2019-03-11 |
| Completed | Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Type 1 Diabetes Mellitus | Phase 3 | 2019-03-11 |
| Completed | Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glar Type 2 Diabetes Mellitus | Phase 3 | 2019-02-19 |
| Completed | Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insuffici Type 2 Diabetes Mellitus | Phase 3 | 2019-02-15 |
| Completed | A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fas Type 2 Diabetes Mellitus, Healthy Subjects | Phase 1 | 2019-01-25 |
| Completed | Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma Asthma | Phase 3 | 2019-01-25 |
| Completed | Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects Type 2 Diabetes Mellitus, Healthy Subjects | Phase 1 | 2019-01-14 |
| Terminated | A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as M Metastatic Neoplasm | Phase 1 | 2019-01-03 |
| Completed | Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2018-12-19 |
| Completed | Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus U Type 2 Diabetes Mellitus | Phase 4 | 2018-12-18 |
| Terminated | Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis | Phase 1 | 2018-12-14 |
| Terminated | A Study of Isatuximab-based Therapy in Participants With Lymphoma Lymphoma | Phase 1 / Phase 2 | 2018-12-11 |
| Terminated | Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adeq Type 2 Diabetes Mellitus | Phase 3 | 2018-11-30 |
| Terminated | Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adeq Type 2 Diabetes Mellitus | Phase 3 | 2018-11-27 |
| Terminated | Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA Giant Cell Arteritis | Phase 3 | 2018-11-20 |
| Terminated | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Con Type 2 Diabetes Mellitus | Phase 3 | 2018-11-09 |
| Completed | Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single a Healthy Volunteers | Phase 1 | 2018-11-08 |
| Terminated | First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukaemia | Phase 1 / Phase 2 | 2018-10-24 |
| Completed | Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relaps Multiple Myeloma | Phase 1 | 2018-10-22 |
| Completed | Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Ye Influenza | — | 2018-10-10 |
| Terminated | Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica Polymyalgia Rheumatica | Phase 3 | 2018-10-09 |
| Completed | Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal Epilepsy | Phase 1 | 2018-10-05 |
| Terminated | Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Type 2 Diabetes Mellitus | Phase 3 | 2018-09-26 |
| Completed | Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis Rhinitis Seasonal | Phase 3 | 2018-09-17 |
| Completed | Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefe Plasmodium Falciparum Infection | Phase 2 | 2018-09-11 |
| Completed | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholester Hypercholesterolemia | Phase 3 | 2018-08-31 |
| Completed | Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) Asthma | Phase 3 | 2018-08-30 |
| Recruiting | A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthr Juvenile Idiopathic Arthritis | Phase 2 | 2018-08-09 |
| Terminated | Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Pat Neoplasm | Phase 1 / Phase 2 | 2018-08-06 |
| Completed | Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patien Chronic Obstructive Pulmonary Disease | Phase 2 | 2018-07-16 |
| Completed | Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis Pharyngitis | Phase 3 | 2018-06-30 |
| Completed | Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) Asthma | Phase 3 | 2018-06-21 |
| Completed | Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Pa Type 2 Diabetes Mellitus | Phase 3 | 2018-06-19 |
| Completed | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholest Hypercholesterolaemia | Phase 3 | 2018-05-31 |
| Completed | An Observational Study on Sarilumab-exposed Pregnancies Rheumatoid Arthritis -Exposure During Pregnancy | — | 2018-05-18 |
| Completed | Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabet Type 1 Diabetes Mellitus | Phase 1 | 2018-05-10 |
| Completed | Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibr Cystic Fibrosis | Phase 1 / Phase 2 | 2018-05-10 |
| Completed | A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administr Food Allergy | Phase 1 | 2018-05-07 |
| Terminated | Effect of Efpeglenatide on Cardiovascular Outcomes Type 2 Diabetes Mellitus | Phase 3 | 2018-04-27 |
| Completed | A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects Type 2 Diabetes Mellitus | Phase 1 | 2018-04-18 |
| Completed | Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Gaucher's Disease Type I, Gaucher's Disease Type III | Phase 3 | 2018-04-11 |
| Completed | Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients W Hypercholesterolaemia | Phase 3 | 2018-03-29 |
| Completed | Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants Asthma | Phase 2 | 2018-03-12 |
| Completed | Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderat Diabetes Mellitus | Phase 2 | 2018-03-12 |
| Completed | Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patient Microvascular Coronary Artery Disease | Phase 1 | 2018-03-07 |
| Completed | Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using T Diabetes | — | 2018-03-06 |
| Completed | Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 4 | 2018-03-05 |
| Completed | Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Plasma Cell Myeloma | Phase 1 / Phase 2 | 2018-02-21 |
| Terminated | Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mell Type 2 Diabetes Mellitus | Phase 3 | 2018-02-20 |
| Completed | Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL Type I Diabetes Mellitus | Phase 4 | 2018-01-22 |
| Completed | Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Thera Type 2 Diabetes Mellitus | Phase 4 | 2018-01-20 |
| Completed | A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus P Type 2 Diabetes Mellitus | Phase 1 | 2018-01-19 |
| Completed | Acne Vulgaris Related Microbiology and Serology Acne Vulgaris | — | 2018-01-18 |
| Completed | A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril Diabetes Mellitus, Healthy Subjects | Phase 1 | 2018-01-15 |
| Terminated | Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies Prostate Cancer, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2018-01-04 |
| Completed | A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide Type 2 Diabetes Mellitus | Phase 1 | 2018-01-03 |
| Completed | A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Gaucher's Disease | Phase 1 | 2018-01-01 |
| Completed | A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Dia Type 2 Diabetes Mellitus | Phase 1 | 2017-12-20 |
| Completed | Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapi Type 1 Diabetes | Phase 1 | 2017-12-13 |
| Active Not Recruiting | A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dex Plasma Cell Myeloma | Phase 3 | 2017-12-07 |
| Completed | Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Influenza, Flu | Phase 4 | 2017-11-03 |
| Completed | Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethas Plasma Cell Myeloma | Phase 3 | 2017-10-25 |
| Completed | Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 1 | 2017-10-18 |
| Completed | Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors Neoplasm Malignant | Phase 1 | 2017-10-17 |
| Completed | Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes Type 1 Diabetes | Phase 4 | 2017-10-13 |
| Terminated | A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Microvascular Coronary Artery Disease | Phase 2 | 2017-10-12 |
| Terminated | Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies i Breast Cancer | Phase 1 / Phase 2 | 2017-09-20 |
| Terminated | Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Type 1 Diabetes Mellitus | Phase 4 | 2017-09-19 |
| Completed | A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transpl End-stage Renal Disease | Phase 4 | 2017-08-16 |
| Completed | Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glarg Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus | Phase 3 | 2017-08-02 |
| Completed | Sotagliflozin Bioequivalence Study Type 2 Diabetes Mellitus | Phase 1 | 2017-06-29 |
| Completed | A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bi Diabetes Mellitus | Phase 1 | 2017-06-12 |
| Completed | A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Malignant Solid Tumor | Phase 1 | 2017-06-09 |
| Completed | Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China Hyperphosphatemia | Phase 3 | 2017-06-07 |
| Completed | A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Dia Type 2 Diabetes Mellitus | Phase 1 | 2017-05-17 |
| Completed | Evaluation of Dupilumab in Children With Uncontrolled Asthma Asthma | Phase 3 | 2017-04-21 |
| Completed | Observational Study Describing the Immune Profile Induced By Pertussis Vaccines Whooping Cough, Pertussis | — | 2017-04-12 |
| Terminated | Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Ne Triple Negative Breast Cancer | Phase 2 | 2017-03-23 |
| Completed | Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorder (Healthy Volunteers) | Phase 1 | 2017-03-17 |
| Completed | Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of So Diabetes Mellitus | Phase 1 | 2017-03-14 |
| Terminated | Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia T-cell Type Acute Leukemia-Precursor, T-lymphoblastic Lymphoma/Leukaemia | Phase 2 | 2017-03-08 |
| Completed | Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin Diabetes Mellitus | Phase 1 | 2017-02-27 |
| Completed | PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adul Gastroesophageal Reflux Disease | Phase 1 | 2017-02-24 |
| Completed | Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrol Diabetes Mellitus, Type 2 | Phase 4 | 2017-02-23 |
| Completed | A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Type1 Diabetes Mellitus | Phase 1 | 2017-02-17 |
| Completed | Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in H Gastroesophageal Reflux Disease | Phase 1 | 2017-02-09 |
| Withdrawn | Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute My Acute Myeloid Leukemia NOS | Phase 2 | 2017-02-01 |
| Terminated | Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Secondary Hyperparathyroidism-Chronic Kidney Disease | Phase 3 | 2017-01-19 |
| Completed | Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamet Plasma Cell Myeloma | Phase 3 | 2016-12-22 |
| Completed | Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Systemic Sclerosis | Phase 2 | 2016-12-21 |
| Completed | A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) | Phase 3 | 2016-12-05 |
| Completed | A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2016-12-02 |
| Completed | A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis Progressive Multiple Sclerosis | Phase 1 | 2016-12-01 |
| Completed | A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Ad Rhinitis Allergic | Phase 3 | 2016-11-30 |
| Completed | A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insuli Type 2 Diabetes Mellitus | Phase 4 | 2016-11-30 |
| Completed | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alir Hypercholesterolemia | Phase 1 | 2016-11-29 |
| Completed | Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) | Phase 3 | 2016-11-28 |
| Completed | Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Cor Hypercholesterolemia, Acute Coronary Syndrome | Phase 4 | 2016-11-15 |
| Withdrawn | Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease Dementia Alzheimer's Type | Phase 2 | 2016-11-01 |
| Completed | Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) Acquired Thrombotic Thrombocytopenic Purpura | Phase 3 | 2016-10-06 |
| Completed | A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol Type 2 Diabetes Mellitus | Phase 1 | 2016-10-01 |
| Completed | An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents Wit Hypercholesterolaemia | Phase 2 | 2016-09-15 |
| Completed | Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (G Diabetes Mellitus, Type 2 | Phase 4 | 2016-09-09 |
| Completed | Resection Observatory Metastatic Colorectal Cancer, Colorectal Neoplasms | — | 2016-09-07 |
| Completed | An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticu Juvenile Idiopathic Arthritis | Phase 2 | 2016-09-06 |
| Completed | Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients Multiple Myeloma | Phase 1 / Phase 2 | 2016-09-05 |
| Completed | Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Ty Type 2 Diabetes Mellitus | Phase 3 | 2016-08-24 |
| Completed | Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Type 2 Diabetes Mellitus | Phase 4 | 2016-08-23 |
| Completed | Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With H Hypercholesterolemia | Phase 3 | 2016-07-27 |
| Completed | Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor A Type 2 Diabetes Mellitus | Phase 3 | 2016-07-06 |
| Completed | Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Type 2 Diabetes Mellitus | Phase 3 | 2016-05-23 |
| Completed | Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequ Diabetes Mellitus, Type 2 | Phase 4 | 2016-05-19 |
| Completed | Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabe Type 2 Diabetes Mellitus | Phase 3 | 2016-05-17 |
| Completed | Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Type 2 Diabetes Mellitus | Phase 3 | 2016-05-09 |
| Completed | A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Ty Type 1 Diabetes Mellitus | Phase 4 | 2016-05-05 |
| Completed | Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabe Type 1 Diabetes Mellitus | Phase 3 | 2016-04-14 |
| Withdrawn | Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Systemic Lupus Erythematosus | Phase 1 | 2016-04-01 |
| Withdrawn | A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison Type 1 Diabetes Mellitus | Phase 1 | 2016-04-01 |
| Completed | Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patien Type 2 Diabetes Mellitus | Phase 1 | 2016-04-01 |
| Completed | Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients W Dyslipidemia | Phase 4 | 2016-03-15 |
| Completed | Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma Asthma | Phase 2 | 2016-01-27 |
| Completed | Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Canc Breast Cancer Metastatic | Phase 2 | 2016-01-23 |
| Completed | Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin Treatme Diabetes Mellitus, Type 2 | Phase 4 | 2016-01-04 |
| Completed | A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Diabetes Mellitus, Type 2 | Phase 4 | 2015-12-21 |
| Completed | Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Touj Type 2 Diabetes Mellitus | Phase 3 | 2015-12-01 |
| Completed | A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Compari Type 1 Diabetes Mellitus | Phase 1 | 2015-12-01 |
| Completed | Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-sta Hypercholesterolemia | Phase 3 | 2015-11-30 |
| Completed | Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan Diabetes Mellitus, Type 2 | Phase 4 | 2015-11-22 |
| Completed | Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Cas Prostate Cancer Metastatic | Phase 4 | 2015-11-09 |
| Completed | A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Diabetes Mellitus, Type 2 | Phase 4 | 2015-11-05 |
| Completed | Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusi Type 1 Diabetes Mellitus | Phase 1 | 2015-11-01 |
| Completed | A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification Neoplasm Malignant | Phase 2 | 2015-11-01 |
| Completed | Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patie Hypercholesterolaemia | Phase 3 | 2015-10-23 |
| Completed | Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma Asthma | Phase 3 | 2015-10-15 |
| Completed | A Study of SAR428926 in Patients With Advanced Solid Tumors Neoplasm Malignant | Phase 1 | 2015-10-05 |
| Completed | Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalid Plasma Cell Myeloma | Phase 1 | 2015-09-30 |
| Completed | Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Me Type 2 Diabetes Mellitus | Phase 4 | 2015-09-07 |
| Completed | A National Study in Patients With Unexplained Splenomegaly Gaucher Disease, Splenomegaly | — | 2015-09-01 |
| Completed | A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate Gaucher Disease | Phase 1 | 2015-09-01 |
| Completed | 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and Open Angle Glaucoma -Ocular Hypertension | Phase 1 | 2015-09-01 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma Plasma Cell Myeloma | Phase 1 | 2015-09-01 |
| Completed | Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases Hepatic and Hepatobiliary Disorders | Phase 3 | 2015-08-01 |
| Terminated | To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Plasmodium Falciparum Infection | Phase 2 | 2015-07-25 |
| Completed | Efficacy and Tolerability Study of Avanafil in Russia Sexual Function and Fertility Disorders NEC-Erectile Dysfunction | Phase 3 | 2015-07-01 |
| Completed | Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholester Hypercholesterolemia | Phase 3 | 2015-06-23 |
| Terminated | Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Cas Prostate Cancer Metastatic | Phase 2 | 2015-06-17 |
| Completed | A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROG Diabetes Mellitus, Type 2 | Phase 4 | 2015-06-16 |
| Completed | SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients Plasma Cell Myeloma | Phase 1 | 2015-05-15 |
| Completed | Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2015-05-01 |
| Completed | Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 2 | 2015-05-01 |
| Terminated | Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Com Pneumonia | Phase 4 | 2015-04-30 |
| Completed | Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) Asthma | Phase 3 | 2015-04-27 |
| Completed | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients Prostate Cancer | Phase 4 | 2015-04-01 |
| Terminated | Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients Type II Diabetes Mellitus | Phase 2 | 2015-04-01 |
| Completed | A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergi Rhinitis Allergic | Phase 3 | 2015-03-01 |
| Completed | Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients Type 2 Diabetes Mellitus | Phase 3 | 2015-03-01 |
| Completed | Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 1 | 2015-03-01 |
| Completed | A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese P Rheumatoid Arthritis | Phase 3 | 2015-02-01 |
| Completed | Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MO Rheumatoid Arthritis | Phase 3 | 2015-01-28 |
| Completed | A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Prod Healthy Volunteers | Phase 1 | 2015-01-05 |
| Completed | Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2015-01-01 |
| Completed | Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia | Phase 3 | 2015-01-01 |
| Completed | Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insuffi Type 2 Diabetes Mellitus | Phase 3 | 2015-01-01 |
| Completed | Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformi Type 2 Diabetes Mellitus | Phase 3 | 2014-12-01 |